E3 Ubiquitin Ligase NEDD4L Negatively Regulates Skin Tumorigenesis by Inhibiting IL-6/GP130 Signaling Pathway
Journal of Investigative Dermatology · 2024
DOI: 10.1016/j.jid.2024.03.030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2024. Verfasst von Huan Liu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an, China; Shaanxi Provincial Key Laboratory of Brain Diseases, Xi'an Med…. Hauptthemen laut MEDLINE: Carcinogenesis, Carcinoma, Squamous Cell, Cytokine Receptor gp130, Interleukin-6. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Shaanxi Province Department of Science and Technology, National Natural Science Foundation of China, Education Department of Shaanxi Provincial government.
Abstract (Originalsprache)
IL-6 signaling plays a crucial role in the survival and metastasis of skin cancer. NEDD4L acts as a suppressor of IL-6 signaling by targeting GP130 degradation. However, the effects of the NEDD4L-regulated IL-6/GP130 signaling pathway on skin cancer remain unclear. In this study, protein expression levels of NEDD4L and GP130 were measured in tumor tissues from patients with cutaneous squamous cell carcinoma. Skin tumors were induced in wild-type and Nedd4l-knockout mice, and activation of the IL-6/GP130/signal transducer and activator of transcription 3 signaling pathway was detected. The results indicated a negative correlation between the protein expression levels of NEDD4L and GP130 in cutaneous squamous cell carcinoma tissues from patients. Nedd4l deficiency significantly promoted 7,12-dimethylbenz[a]anthracene/12-O-tetradecanoylphorbol-13-acetate-induced skin tumorigenesis and benign-to-malignant conversion by activating the IL-6/GP130/signal transducer and activator of transcription 3 signaling pathway, which was abrogated by supplementation with the GP130 inhibitor SC144. Furthermore, our findings suggested that NEDD4L can interact with GP130 and promote its ubiquitination in skin tumors. In conclusion, our results indicate that NEDD4L could act as a tumor suppressor in skin cancer, and inhibition of GP130 could be a potential therapeutic method for treating this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an, China; Shaanxi Provincial Key Laboratory of Brain Diseases, Xi'an Medical University, Xi'an, China.
- Institute of Immunology, School of Medicine, Zhejiang University, Hangzhou, China.
- School of Clinical Medicine, Xi'an Medical University, Xi'an, China.
- College of pharmacy, Xi'an Medical University, Xi'an, China.
- Department of Immunology, Xi'an Medical University, Xi'an, China.
- Department of Orthopedics, Tangdu Hospital, Air Force Military Medical University, Xi'an, China. Electronic address: liaobo@fmmu.edu.cn.
Förderung
- Shaanxi Province Department of Science and Technology
- National Natural Science Foundation of China
- Education Department of Shaanxi Provincial government
Zitieren
APA
Liu, H., Wang, N., Yang, R., Luan, J., Cao, M., Zhai, C., Wang, S., Wei, M., Wang, D., Qiao, J., Liu, Y., She, W., Guo, N., Liao, B., & Gou, X. (2024). E3 Ubiquitin Ligase NEDD4L Negatively Regulates Skin Tumorigenesis by Inhibiting IL-6/GP130 Signaling Pathway. Journal of Investigative Dermatology. https://doi.org/10.1016/j.jid.2024.03.030
Vancouver
Liu H, Wang N, Yang R, Luan J, Cao M, Zhai C, et al. E3 Ubiquitin Ligase NEDD4L Negatively Regulates Skin Tumorigenesis by Inhibiting IL-6/GP130 Signaling Pathway. Journal of Investigative Dermatology. 2024. doi:10.1016/j.jid.2024.03.030
BibTeX
@article{Liu2024,
author = {Liu, Huan and Wang, Ning and Yang, Run and Luan, Jing and Cao, Meng and Zhai, Cui and Wang, Shan and Wei, Mengqian and Wang, Duorong and Qiao, Jiayue and Liu, Yuqian and She, Wenting and Guo, Na and Liao, Bo and Gou, Xingchun},
title = {E3 Ubiquitin Ligase NEDD4L Negatively Regulates Skin Tumorigenesis by Inhibiting IL-6/GP130 Signaling Pathway},
journal = {Journal of Investigative Dermatology},
year = {2024},
doi = {10.1016/j.jid.2024.03.030}
}
EUVIMED